Triple-negative breast cancer (TNBC) is a unique subtype of breast cancer in which the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) are not expressed (Perou et al., 2000). This evidence concerns the gene ESR1 and breast carcinoma.